Evidence map›Paper›PMID 40296985›Full record

ArticleOphthalmology science

Transplant of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Strips for Macular Degeneration and Retinitis Pigmentosa.

Daiki Sakai, Michiko Mandai, Yasuhiko Hirami, Midori Yamamoto, Shin-Ichiro Ito, Saori Igarashi, Satoshi Yokota, Hirofumi Uyama, Masashi Fujihara, Akiko Maeda and 12 more

Abstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. 3D epigenomic landscape of the human retinal pigment epithelium.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Management of full-thickness macular holes in patients with retinitis pigmentosa - a case series of 5 patients operated with pars plana vitrectomy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  6. Observational
  7. Cell therapy for age-related macular degeneration.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Therapeutic potential of allogeneic iPS cell-derived RPE transplantation forAmerican journal of ophthalmology case reports · 2025
    Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Daiki SakaiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Michiko MandaiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Yasuhiko HiramiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Midori YamamotoDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Shin-Ichiro ItoDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Saori IgarashiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Satoshi YokotaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Hirofumi UyamaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Masashi FujiharaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Akiko MaedaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Motoki TeradaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Mitsuhiro NishidaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Yumiko ShibataDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Naoko HayashiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Kyoko IsekiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Takuya MiuraDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Keisuke KajitaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Masaaki IshidaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Sunao SugitaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Tadao MaedaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Masayo TakahashiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Yasuo KurimotoDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To explore the safety and efficacy of the allogeneic induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) strip transplantation for patients with RPE degeneration. Design: Single-arm, open-label, interventional study. Participants: Three eyes from 3 patients clinically diagnosed with RPE impairment disease; 1 patient had dry age-related macular degeneration (AMD), and remaining 2 patients had Intervention: Allogeneic iPSC-derived RPE strip transplantation was performed by a 25-gauge pars plana vitrectomy. The RPE strips were prepared by incubating iPSC-derived RPE cells in 2-mm-wide grooves in the mold. Artificial retinal detachment was generated using a 38-gauge subretinal cannula, and the RPE strips were injected into the retinal bleb using a 31-gauge cannula with the maximum graft dose limited to 2 strips. Main Outcome Measures: The reduction of RPE abnormal area by the engraftment of transplanted allogeneic iPSC-derived RPE cells, which was measured by analyzing fluorescein angiography with an automated evaluation program at pretransplantation and up to 52 weeks posttransplantation. Results: The primary endpoint of reducing abnormal areas of RPE through the survival of the transplanted graft cells was achieved in all patients at 52 weeks posttransplantation. Visual function assessments confirmed significant vision-related quality of life improvement and potential retinal sensitivity restoration in 1 patient with dry AMD. The successful subretinal delivery of the iPSC-derived RPE strips was confirmed during and immediately after surgery. The engraftment of RPE cells migrated out from the strips was observed using polarization-sensitive OCT specifically and visualized as characteristic hexagonal cells via adaptive optics imaging in all patients. While no serious adverse events occurred, suspected immune reactions to graft cells and epiretinal membrane formation were observed in 1 patient each. Conclusions: A decrease in the RPE abnormal area by reliable delivery of allogeneic iPSC-derived RPE strips was achieved in all 3 cases with no serious adverse events. Further long-term studies and larger cohorts with better preoperative vision are warranted to evaluate the safety and efficacy of RPE strip transplantation. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Age-related macular degenerationiPS cellsRetinal pigment epitheliumRetinitis pigmentosaRPE transplantation

Identifiers

PMID40296985
PMCPMC12036055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.